Roche Agrees To Purchase Genentech for $47 Billion
Genentech's board has approved and recommended a deal in which pharmaceutical company Roche will pay $95 per share for the 44% of Genentech that it does not already own. Roche's initial bid of $89 per share was rejected by Genentech's board in July 2008.
- "Roche To Take Over Genentech for $47 Billion" (Higgins, AP/San Francisco Chronicle, 3/12).
- "Roche Agrees To Buy Genentech" (Jolly, New York Times, 3/12).